Prosci/B7-H4重组蛋白/90-369/100μg
商品编号:
90-369
品牌:
prosci-inc
市场价:
¥8500.00
美元价:
5100.00
产品分类:
其它重组蛋白
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
Specifications
SPECIES: | Human |
---|---|
SOURCE SPECIES: | CHO cells |
SEQUENCE: | The extracellular domain of human B7-H4 (aa 29-258) is fused to the N-terminus of the Fc region of human IgG1. |
FUSION TAG: | Fc Tag |
TESTED APPLICATIONS: | |
APPLICATIONS: | This recombinant proteins is for research use only. |
BIOLOGICAL ACTIVITY: | Measured by the ablility to inhibit anti-CD3-induced proliferation of stimulated human T cells. Human T lymphocytes cultured for 72 hours with PHA were incubated for an additional 3 days in 96 well place coated with 500 ng/ml anti-CD3 and 10ug/ml human B7H4/Fc. The presence of human B7H4/Fc at 10ug/ml inhibited anti CD3 response by 30-50%. Optimal dilutions should be determined by each laboratory for each application. |
Properties
PURITY: | >98% (SDS-PAGE) |
---|---|
PHYSICAL STATE: | Lyophilized |
BUFFER: | Lyophilized from 0.2um-filtered solution in PBS. |
STORAGE CONDITIONS: | Stable for at least 1 year after receipt when stored at -20˚C. Working aliquots are stable for up to 3 months when stored at -20˚C. |
Additional Info
ALTERNATE NAMES: | V-set Domain-containing T Cell Activation Inhibitor 1, VTCN1, B7h.5, Immune Costimulatory Protein B7-H4, T Cell Costimulatory Molecule B7x, Protein B7S1 |
---|---|
ACCESSION NO.: | NP_078902 |
PROTEIN GI NO.: | 99028881 |
Background
B7H4 is a B7 family member that negatively regulates T cell immunity by inhibiting of T cell proliferation, cytokine production, and cell cycle progression. In vitro, B7H4 inhibits CD4+ and CD8+ T cell proliferation, cytokine production, and generation of alloreactive cytotoxic T-cells (CTLs). In vivo, blockade of endogenous B7-H4 by specific monoclonal antibody promotes T cell responses. B7-H4 ia an important negative regulator of innate immunity through growth inhibition of neutrophils. B7-H4 is expressed on some tumor cancer cells. The role of B7-H4 in tumor progression may be to transform precancerous cells and then protect them from immunosurveillance. |
品牌介绍
ProSci我们是抗体开发公司中的领导者。我们的研究抗体,定制抗体开发服务和领先的研究计划可帮助科学家,实验室技术人员,研究人员和其他技术人员降低研究成本,灵活而广泛的抗体服务,在线支持以及丰富的抗体使用第一手知识因为它们与特定的免疫化学应用有关。
联络我们